Clinical Trials
32 trialsVIALE-T
AbbVie
FLUBUTBI
Hackensack Meridian Health
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Delta-Fly Pharma, Inc.
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
Apollomics Inc.
DEXAML-03
University Hospital, Toulouse
ENHANCE-3
Gilead Sciences
ENHANCE-2
Gilead Sciences
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
GlycoMimetics Incorporated
AML
Jazz Pharmaceuticals
Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML
Kronos Bio
Panobinostat Maintenance After HSCT fo High-risk AML and MDS
Goethe University
Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML
Cornerstone Pharmaceuticals
CATHY
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
BMT CTN 0901
Medical College of Wisconsin
GnG
University Hospital Heidelberg
HATCY
Kiadis Pharma
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
Wake Forest University Health Sciences
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Helsinn Healthcare SA
MIRROS
Hoffmann-La Roche
AML
University Hospital Carl Gustav Carus
HCT Versus CT in Elderly AML
European Society for Blood and Marrow Transplantation
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
University of Ulm
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Takeda
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Stanford University
CASCADE
Seagen Inc.
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
OHSU Knight Cancer Institute
CICLODECH
Hospital Israelita Albert Einstein
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
University Hospital Carl Gustav Carus
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide
University Hospital Muenster
Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc.
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
Acute Leukemia French Association
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
University of Cologne